ANAC Insider Trading
ANAC | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at ANAC provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2016-06-04 04:00 | 2016-06-01 | Bell Graeme | Officer - Executive VP and CFO | SELL | $99.28 | 751 | $74,559 | 10,255 | -6.8% |
| 2016-05-25 04:04 | 2016-05-23 | Leonard Keith R | Director | OPT+S | $99.70 | 9,000 | $897,300 | 794 | 0.0% |
| 2016-05-19 00:44 | 2016-05-16 | Hove Anders D | Director | SELL | $99.59 | 353,881 | $35,241,699 | 0 | -100.0% |
| 2016-04-30 04:00 | 2016-04-29 | Sullivan Ryan T | Officer - EVP and General Counsel | SELL | $66.33 | 3,125 | $207,281 | 30,132 | -9.4% |
| 2016-04-11 23:33 | 2016-04-07 | Hove Anders D | Director | SELL | $71.10 | 229,301 | $16,303,943 | 96,234 | -70.4% |
| 2016-03-23 04:00 | 2016-03-22 | BERNS PAUL L | Director, Officer - President and CEO | SELL | $60.31 | 37,500 | $2,261,614 | 230,311 | -14.0% |
| 2016-03-05 05:00 | 2016-03-02 | IPPOLITO VINCENT P | Officer - EVP & Chief Commercial Officer | SELL | $63.86 | 9,000 | $574,753 | 67,985 | -11.7% |
| 2016-01-22 05:00 | 2016-01-19 | IPPOLITO VINCENT P | Officer - EVP & Chief Commercial Officer | OPT+S | $95.41 | 20,000 | $1,908,204 | 70,985 | 0.0% |
| 2016-01-20 05:00 | 2016-01-15 | Zane Lee | Officer - SVP and Chief Medical Officer | SELL | $89.57 | 1,466 | $131,310 | 27,281 | -5.1% |
| 2016-01-06 05:33 | 2016-01-04 | IPPOLITO VINCENT P | Officer - EVP & Chief Commercial Officer | SELL | $112.28 | 855 | $96,002 | 70,985 | -1.2% |
| 2016-01-06 05:31 | 2016-01-04 | Sullivan Ryan T | Officer - Sr. VP and General Counsel | SELL | $111.78 | 733 | $81,935 | 27,007 | -2.6% |
| 2016-01-06 05:30 | 2016-01-04 | BERNS PAUL L | Director, Officer - President and CEO | SELL | $112.35 | 2,533 | $284,582 | 252,227 | -1.0% |
| 2015-12-18 05:01 | 2015-12-15 | Zane Lee | Officer - SVP and Chief Medical Officer | OPT+S | $113.17 | 14,000 | $1,584,346 | 28,747 | 0.0% |
| 2015-12-18 01:13 | 2015-12-15 | Hove Anders D | Director | SELL | $111.25 | 900,000 | $100,125,000 | 325,535 | -73.4% |
| 2015-12-16 05:00 | 2015-12-11 | BERNS PAUL L | Director, Officer - President and CEO | OPT+S | $117.26 | 20,000 | $2,345,246 | 254,760 | 0.0% |
| 2015-12-16 01:09 | 2015-12-11 | Hove Anders D | Director | SELL | $117.36 | 40,000 | $4,694,400 | 33,886 | -54.1% |
| 2015-12-12 03:02 | 2015-12-10 | Sullivan Ryan T | Officer - Sr. VP and General Counsel | OPT+S | $110.41 | 10,000 | $1,104,105 | 27,740 | 0.0% |
| 2015-12-12 03:00 | 2015-12-09 | IPPOLITO VINCENT P | Officer - EVP & Chief Commercial Officer | OPT+S | $107.90 | 20,000 | $2,158,092 | 71,840 | 0.0% |
| 2015-11-13 00:59 | 2015-11-10 | Hove Anders D | Director | SELL | $103.60 | 100,295 | $10,390,562 | 1,598,517 | -5.9% |
| 2015-09-18 04:46 | 2015-09-15 | BERNS PAUL L | Director, Officer - President and CEO | OPT+S | $139.83 | 20,000 | $2,796,528 | 254,760 | 0.0% |
| 2015-09-18 04:45 | 2015-09-15 | Zane Lee | Officer - SVP and Chief Medical Officer | OPT+S | $139.84 | 14,000 | $1,957,700 | 28,744 | 0.0% |
| 2015-08-18 03:00 | 2015-08-13 | BERNS PAUL L | Director, Officer - President and CEO | OPT+S | $138.69 | 20,000 | $2,773,878 | 254,760 | 0.0% |
| 2015-06-18 01:56 | 2015-06-15 | Zane Lee | Officer - SVP and Chief Medical Officer | OPT+S | $69.05 | 12,000 | $828,590 | 28,156 | 0.0% |
| 2015-06-03 03:00 | 2015-06-01 | Maples Kirk R | Officer - SVP, Program Management | SELL | $70.31 | 600 | $42,188 | 7,220 | -7.7% |
| 2015-05-16 03:18 | 2015-05-15 | Plattner Jacob j | Officer - Senior VP, Research | SELL | $63.73 | 8,920 | $568,472 | 17,840 | -33.3% |
| 2015-05-15 04:12 | 2015-05-12 | Maples Kirk R | Officer - SVP, Program Management | OPT+S | $61.07 | 6,060 | $370,087 | 7,820 | 0.0% |
| 2015-05-15 04:11 | 2015-05-12 | Rodriguez Carmen R | Officer - Snr VP Reg Afrs & Qual. Assur. | OPT+S | $62.73 | 61,942 | $3,885,324 | 7,020 | 0.0% |
| 2015-05-02 02:25 | 2015-05-01 | Maples Kirk R | Officer - SVP, Program Management | SELL | $53.95 | 600 | $32,370 | 7,820 | -7.1% |
| 2015-05-02 00:01 | 2015-04-29 | Sullivan Ryan T | Officer - Sr. VP and General Counsel | SELL | $53.61 | 3,125 | $167,531 | 27,740 | -10.1% |
| 2015-04-29 03:37 | 2015-04-24 | BERNS PAUL L | Director, Officer - President and CEO | SELL | $63.64 | 50,000 | $3,181,820 | 253,760 | -16.5% |
| 2015-04-17 23:06 | 2015-04-15 | Plattner Jacob j | Officer - Senior VP, Research | SELL | $62.81 | 8,920 | $560,265 | 26,760 | -25.0% |
| 2015-04-03 23:07 | 2015-04-01 | Maples Kirk R | Officer - SVP, Program Management | SELL | $57.02 | 600 | $34,209 | 8,420 | -6.7% |
| 2015-03-24 01:55 | 2015-03-23 | Parker Geoffrey M. | Officer - Executive Vice President & CFO | BUY | $52.43 | 3,000 | $157,304 | 173,000 | +1.8% |
| 2015-03-24 01:53 | 2015-03-19 | BERNS PAUL L | Director, Officer - President and CEO | SELL | $56.07 | 37,500 | $2,102,644 | 308,760 | -10.8% |
| 2015-03-19 02:35 | 2015-03-16 | Plattner Jacob j | Officer - Senior VP, Research | SELL | $55.60 | 8,920 | $495,952 | 35,680 | -20.0% |
| 2015-03-19 02:33 | 2015-03-16 | Zane Lee | Officer - SVP and Chief Medical Officer | OPT+S | $56.44 | 12,000 | $677,225 | 28,156 | 0.0% |
| 2015-03-05 03:22 | 2015-03-04 | Chanda Sanjay | Officer - SVP, Drug Development | OPT+S | $45.00 | 5,000 | $225,000 | 29,087 | 0.0% |
| 2015-03-05 03:20 | 2015-03-03 | IPPOLITO VINCENT P | Officer - EVP & Chief Commercial Officer | SELL | $43.88 | 9,000 | $394,936 | 70,603 | -11.3% |
| 2015-03-05 03:18 | 2015-03-02 | Plattner Jacob j | Officer - Senior VP, Research | SELL | $44.02 | 6,875 | $302,656 | 44,600 | -13.4% |
| 2015-03-05 03:17 | 2015-03-02 | Maples Kirk R | Officer - SVP, Program Management | SELL | $43.95 | 600 | $26,369 | 9,020 | -6.2% |
| 2015-02-05 00:10 | 2015-02-02 | Maples Kirk R | Officer - SVP, Program Management | SELL | $37.41 | 600 | $22,448 | 4,600 | -11.5% |
| 2015-02-05 00:08 | 2015-02-02 | Plattner Jacob j | Officer - Senior VP, Research | SELL | $37.35 | 6,875 | $256,781 | 51,475 | -11.8% |
| 2015-01-07 00:27 | 2015-01-02 | Plattner Jacob j | Officer - Senior VP, Research | SELL | $32.09 | 6,875 | $220,619 | 58,350 | -10.5% |
| 2015-01-07 00:25 | 2015-01-02 | Maples Kirk R | Officer - SVP, Program Management | SELL | $31.96 | 600 | $19,174 | 4,200 | -12.5% |
| 2014-12-30 00:07 | 2014-12-26 | BERNS PAUL L | Director, Officer - President and CEO | SELL | $30.82 | 25,000 | $770,505 | 325,000 | -7.1% |
| 2014-12-13 02:49 | 2014-12-10 | Shapiro Lucy | Director | OPT+S | $35.11 | 289,685 | $10,169,479 | 0 | 0.0% |
| 2014-12-13 02:47 | 2014-12-10 | Zane Lee | Officer - SVP and Chief Medical Officer | OPT+S | $36.09 | 4,900 | $176,851 | 7,000 | 0.0% |
| 2014-12-11 03:08 | 2014-12-09 | Maples Kirk R | Officer - SVP, Program Management | OPT+S | $36.52 | 60,000 | $2,191,404 | 4,800 | 0.0% |
| 2014-12-04 03:09 | 2014-12-01 | Plattner Jacob j | Officer - Senior VP, Research | SELL | $33.34 | 6,875 | $229,237 | 65,225 | -9.5% |
| 2014-12-04 03:08 | 2014-12-01 | Maples Kirk R | Officer - SVP, Program Management | SELL | $33.38 | 600 | $20,025 | 4,800 | -11.1% |
How to Interpret $ANAC Trades
Not every insider transaction in ANAC is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ANAC shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for ANAC
Insider activity data for ANAC is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ANAC, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.